This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceuticals Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Kenji Maeda: Innovator in Pharmaceutical Composition
Introduction
Kenji Maeda is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs aimed at combating HIV infection and AIDS.
Latest Patents
Kenji Maeda holds a patent for "Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient." This pharmaceutical composition is designed for the prevention and treatment of HIV infection or AIDS induced by the infection. The active ingredients include triazaspiro[5.5]undecane derivatives, quaternary ammonium salts, N-oxides, or non-toxic salts. These compounds are essential in the fight against HIV and AIDS, providing a potential avenue for effective treatment.
Career Highlights
Maeda is associated with Ono Pharmaceuticals Co., Ltd., where he has been instrumental in advancing research and development in the pharmaceutical sector. His work focuses on innovative solutions to pressing health issues, particularly those related to viral infections.
Collaborations
Kenji Maeda has collaborated with esteemed colleagues such as Yoshikazu Takaoka and Shiro Shibayama. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Kenji Maeda's contributions to pharmaceutical innovation, particularly in the area of HIV treatment, highlight his role as a significant inventor in the field. His work continues to inspire advancements in medical science and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile